DE60224145D1 - Suplatast tosilat kristalle - Google Patents

Suplatast tosilat kristalle

Info

Publication number
DE60224145D1
DE60224145D1 DE60224145T DE60224145T DE60224145D1 DE 60224145 D1 DE60224145 D1 DE 60224145D1 DE 60224145 T DE60224145 T DE 60224145T DE 60224145 T DE60224145 T DE 60224145T DE 60224145 D1 DE60224145 D1 DE 60224145D1
Authority
DE
Germany
Prior art keywords
suplatast tosilate
crystal
tosilate crystals
suplatast
tosilate crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60224145T
Other languages
English (en)
Other versions
DE60224145T2 (de
Inventor
Takanori Ushio
Hidenori Miura
Keiko Nagai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of DE60224145D1 publication Critical patent/DE60224145D1/de
Application granted granted Critical
Publication of DE60224145T2 publication Critical patent/DE60224145T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/12—Sulfonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DE60224145T 2001-04-16 2002-04-16 Suplatasttosilat-kristall Expired - Lifetime DE60224145T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001117165 2001-04-16
JP2001117165 2001-04-16
PCT/JP2002/003762 WO2002083633A1 (fr) 2001-04-16 2002-04-16 Cristaux de tosilate de suplatast

Publications (2)

Publication Number Publication Date
DE60224145D1 true DE60224145D1 (de) 2008-01-31
DE60224145T2 DE60224145T2 (de) 2008-12-11

Family

ID=18967782

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60224145T Expired - Lifetime DE60224145T2 (de) 2001-04-16 2002-04-16 Suplatasttosilat-kristall

Country Status (16)

Country Link
US (1) US7138140B2 (de)
EP (1) EP1295870B1 (de)
JP (1) JP4015954B2 (de)
KR (1) KR100535305B1 (de)
CN (1) CN1205182C (de)
AT (1) ATE381538T1 (de)
AU (1) AU2002248036B2 (de)
CA (1) CA2413087C (de)
CY (1) CY1107112T1 (de)
DE (1) DE60224145T2 (de)
DK (1) DK1295870T3 (de)
ES (1) ES2298358T3 (de)
HK (1) HK1059773A1 (de)
PT (1) PT1295870E (de)
TW (1) TWI241289B (de)
WO (1) WO2002083633A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006006616A1 (ja) * 2004-07-13 2006-01-19 Taiho Pharmaceutical Co., Ltd. トシル酸スプラタスト結晶の均一性の評価方法並びに均一な結晶及びその製造方法
JP4794148B2 (ja) * 2004-09-10 2011-10-19 大鵬薬品工業株式会社 ネフローゼ症候群治療剤
JP4498101B2 (ja) * 2004-11-04 2010-07-07 大鵬薬品工業株式会社 頭痛の予防及び／または治療剤
CA2613030C (en) * 2005-06-27 2011-03-15 Juntendo Educational Foundation Agent for the treatment of herpes virus-derived pain
WO2008078826A1 (ja) * 2006-12-26 2008-07-03 Taiho Pharmaceutical Co., Ltd. 糖尿病性ニューロパチー治療剤
US11819482B2 (en) * 2017-08-29 2023-11-21 Conrig Pharma Aps Composition comprising suplatast tosilate
EP4046633A1 (de) * 2018-06-27 2022-08-24 Algernon Pharmaceuticals Inc. Verwendung von repirinast in der prophylaxe oder behandlung von nierenfibrose oder nierenerkrankung
CN110824088B (zh) * 2019-11-26 2022-04-12 重庆柳江医药科技有限公司 利用hplc-ms测定甲磺司特在血浆中含量的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556737A (en) * 1983-03-11 1985-12-03 Taiho Pharmaceutical Company Limited Sulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the same
DE4107857A1 (de) * 1991-03-12 1992-09-17 Thomae Gmbh Dr K Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
TW264385B (de) * 1993-05-14 1995-12-01 Taiho Pharmaceutical Co Ltd
JP3256376B2 (ja) * 1994-01-27 2002-02-12 大鵬薬品工業株式会社 トシル酸スプラタストの結晶およびその製造方法
JP3563480B2 (ja) 1994-03-10 2004-09-08 大鵬薬品工業株式会社 光学活性体の製造方法、並びに光学活性なスルホニウム化合物
WO1996033741A1 (fr) * 1995-04-24 1996-10-31 Taiho Pharmaceutical Co., Ltd. Remede pour maladies allergiques, a appliquer dans la region du nez
US5965565A (en) * 1996-12-12 1999-10-12 Merck & Co., Inc. Piperidines promote release of growth hormone
JP3634622B2 (ja) 1998-05-01 2005-03-30 大鵬薬品工業株式会社 腎透析に伴うそう痒の治療剤
ATE413869T1 (de) * 1998-11-05 2008-11-15 Taiho Pharmaceutical Co Ltd Behandlung der dysurie

Also Published As

Publication number Publication date
ATE381538T1 (de) 2008-01-15
JPWO2002083633A1 (ja) 2004-08-05
AU2002248036B2 (en) 2005-04-21
US7138140B2 (en) 2006-11-21
DK1295870T3 (da) 2008-01-28
CN1205182C (zh) 2005-06-08
EP1295870A4 (de) 2006-01-18
PT1295870E (pt) 2008-01-10
HK1059773A1 (en) 2004-07-16
CA2413087A1 (en) 2002-12-16
CY1107112T1 (el) 2012-10-24
JP4015954B2 (ja) 2007-11-28
CN1461297A (zh) 2003-12-10
WO2002083633A1 (fr) 2002-10-24
ES2298358T3 (es) 2008-05-16
EP1295870B1 (de) 2007-12-19
KR100535305B1 (ko) 2005-12-08
EP1295870A1 (de) 2003-03-26
DE60224145T2 (de) 2008-12-11
TWI241289B (en) 2005-10-11
CA2413087C (en) 2008-03-11
KR20030029051A (ko) 2003-04-11
US20030149105A1 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
CY1107112T1 (el) Κρυσταλλοι τοζιλικου suplatast
CA2464068A1 (en) .alpha.-form or .beta.-form crystal of (r)-2-(2-aminothiazol-4yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl)acetanilide
EE03127B1 (et) Kristalne magneesiumomeprasool, selle valmistamise protsess, seda sisaldavad ravimpreparaadid ja nende kasutamine
MY138452A (en) Novel process for synthesizing and a novel crystal form of agomelatine as well as pharmaceutical preparations containing these
DK1270575T3 (da) Hidtil ukendt krystallinsk form af et pyrrolidylthiocarbapenemderivat
Beilles et al. Preferential crystallisation and comparative crystal growth study between pure enantiomer and racemic mixture of a chiral molecule: 5-ethyl-5-methylhydantoin
PL352363A1 (en) Dinucleotide crystal
DE69331003T2 (de) Kristalle von derivaten von chinozon carbonsäure-hydraten
NO20011634L (no) Krystall av diuridintetrafosfat eller salter derav, og fremgangsmåte for fremstilling av samme og fremgangsmåte forfremstilling av nevnte forbindelse
DK0697011T3 (da) Store kaliumhydrogencarbonatkrystaller og fremgangsmåde til fremstilling deraf
DE69124330D1 (de) Optisch aktive Thienotriazolodiazepin-Verbindungen
PT91361A (pt) Processo aperfeicoado para a preparacao de diamidas de acidos n,n'-bis- -(alcoxialquil)-piridina-2,4-dicarboxilicos e de composicoes farmaceuticas que as contem
US3895242A (en) Non-linear optical elements
RU2001116105A (ru) Кристаллические формы 3-(2,4-дихлорбензил)-2-метил-n-(пентилсульфонил)-3h-бензимидазол-5- карбоксамида
Jiang et al. Growth of zinc cadmium thiocyanate single crystal for laser diode frequency-doubling
EP1700851A4 (de) Kristallines alkalisches citalopramdiol-zwischenprodukt
PT655441E (pt) Modificacao cristalina de (4-ciclopropil-6-metil-pirimidin-2-il)-fenil-amina, processo para a sua preparacao e sua utilizacao como fungicida
Siddheswaran et al. Growth and characterization of tris allylthiourea mercuric chloride crystals
CA2000184C (en) Trihydrates of sodium l- and d-2-pyrrolidone-5-carboxylate
PT1462439E (pt) Novos cristais estáveis de derivado do ácido fenilpropiónico substituído e processo para a sua produção
ATE433443T1 (de) Neue kristalline und stabile form von andolast
TH50989A (th) รูปผลึกที่ vii ของคาเบอร์โกลีน
WO2002004428A3 (en) Synthesis of chlorinated pyrimidines
JPS6475450A (en) Optically active compound
ATE328869T1 (de) Stabile kristalle von pyrrolverbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition